homeostasis/metabolism
• concentrations of several glycerophospho-N-acyl ethanolamines (GP-NAEs) are significantly decreased in brain, with the most prominent reduction seen in N-16:0 GP-NAE
• modest, but significant reductions of some lyso-N-acyl phosphatidylethanolamines (lyso-NAPEs), including N-16:0, O-18:0 and N-16:0, O-20:4, are detected in brain
• plasmalogen-type lyso-NAPE (lyso-pNAPE) content is markedly reduced in brain
• almost all of the O-16:0 and O-18:0 lyso-N-acyl phosphatidylserine (lyso-NAPS) species are severely reduced in brain tissue, including the most abundant N-16:0, O-18:0 and N-16:0, O-18:1 species
• modest but significant elevations are detected in several N-acyl phosphatidylserine (NAPS) lipids in brain tissue
• however, no significant changes in NAPE, N-acyl ethanolamine (NAE) or plasmalogen-type NAPE (pNAPE) content are observed in brain tissue and the abundance of lyso-NAPS species with unsaturated O-fatty acyl groups on the glycerol backbone as well as N-acyl serine species (NASs) is normal
|
• brain homogenates show significant, but incomplete reductions in N-acyl phosphatidylethanolamine (NAPE)- and lyso-NAPE-lipase activity relative to those from wild-type controls
• brain lysates show significantly decreased pNAPE-lipase activity
|
behavior/neurological
N |
• mice are viable and healthy with no overt abnormalities in home cage behavior
|